Select Page

Title of the project: Risk Evaluation of Potential Environmental Hazards from Low Energy Electromagnetic Field (EMF) Exposure Using Sensitive in vitro Methods

 

Period covered by the progress report 1 February 2000 – 31 May 2004

Results and Milestones: The strengths of REFLEX are based firstly on the adoption of a common technological platform for ELF-EMF and RF-EMF exposures that allow the replication of positive findings between the collaborating partners. Secondly, on the adoption of the post-genomic technologies (DNA micro- arrays and proteomics) that enables very large numbers of potential cellular effects to be examined simultaneously without prejudice as to mechanisms. The data obtained in the course of the REFLEX project showed that ELF-EMF had genotoxic effects on primary cell cultures of human fibroblasts and on other cell lines. These results were obtained in two laboratories and confirmed in two additional laboratories outside the REFLEX project, while no such effects could be observed in a further laboratory. ELF-EMF generated DNA strand breaks at a significant level at a flux density as low as 35 μT. There was a strong positive correlation between both the intensity and duration of exposure to ELF-EMF and the increase in single and double strand DNA breaks and micronuclei frequencies. Surprisingly this genotoxic effect was only observed when cells were exposed to intermittent ELF-EMF, but not to continuous exposure. Responsiveness of fibroblast to ELF- EMF increased with the age of the donor and in the presence of specific genetic repair defects. The effect also differed among the other types of cells examined. In particular, lymphocytes from adult donors were not responsive. Chromosomal aberrations were also observed after ELF-EMF exposure of human fibroblasts. The following observations were made in different REFLEX laboratories: 1) ELF-EMF at a flux density of about 2 mT upregulated the expression of early genes, such as p21, c-jun and egr-1, in p53-deficient mouse embryonic stem cells, but not in healthy wildtype cells; 2) ELF-EMF (0.1 mT) increased the proliferation rate of neuroblastoma cells; and 3) ELF-EMF (0.8 mT) enhanced the differentiation of mouse stem cells into cardiomyocytes. However, no clear-cut and unequivocal effects of ELF-EMF on DNA synthesis, cell cycle, cell differentiation, cell proliferation and apoptosis were found.

With respect to radiofrequency electromagnetic fields (RF-EMF), data showed that RF-EMF produced genotoxic effects in fibroblasts, granulosa cells and HL60 cells. Cells responded to RF-EMF exposure between SAR level 0.3 and 2 W/kg with a significant increase in single and double strand DNA breaks and in micronuclei frequency. Chromosomal aberrations in fibroblasts were observed after RF-EMF exposure. RF- EMF at a SAR of 1.5 W/kg downregulated the expression of neuronal genes in neuronal precursor cells and upregulated the expression of early genes in p53-deficient embryonic stem cells, but not in wildtype cells. Proteomic analyses on human endothelial cell lines showed that exposure to RF-EMF changed the expression and phosphorylation of numerous, largely unidentified proteins. Among these proteins is the heat shock protein hsp27, a marker for cellular stress responses. There was no evidence that RF-EMF affected processes such as cell proliferation, apoptosis or immune cell functionality.

For both ELF-EMF and RF-EMF, the results of the whole genome cDNA micro-array and proteomic analyses indicated that EMF may activate several groups of genes that play a role in cell division, cell proliferation and cell differentiation.